Fig. 3From: Impact of plasma Epstein–Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infectionReceiver operating characteristic (ROC) curve analysis of EBV DNA for the diagnosis of relapseBack to article page